Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 9, 2009, Pages 3642-3649

  Sun, Wenjia ^a,b   Chen, Hongbin ^a,b   Liu, Yudong ^a,b   Zhao, Chunjiang ^a,b   Nichols, Wright W ^c   Chen, Minjun ^a   Zhang, Jianzhong ^d   Yue, Ma ^e   Wang, Hui ^a,b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^c ASTRAZENECA   (United Kingdom)

^d CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^e NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHINA; CONTROLLED STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CHINA; CITIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 70349130359     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00206-09     Document Type: Article

References (35)

1. Ariza, J., M. Pujol, J. Cabo, C. Pena, N. Fernandez, J. Linares, J. Ayats, and F. Gudiol. 1999. Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. Lancet 353:1587-1588.
2. Brunet, F., G. Vedel, F. Dreyfus, J. F. Vaxelaire, T. Giraud, B. Schremmer, and J. F. Monsallier. 1990. Failure of teicoplanin in two neutropenic patients with staphylococcus septicemia who recovered after administration of vancomycin. Eur. J. Clin. Microbiol. Infect. Dis. 9:145-147.
3. Cartolano, G. L., M. Cheron, D. Benabid, M. Leneveu, and A. Boisivon. 2004. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals. Clin. Microbiol. Infect. 10:448-451.
4. Charles, P. G., P. B. Ward, P. D. Johnson, B. P. Howden, and M. L. Grayson. 2004. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin. Infect. Dis. 38:448-451.
5. Chi, C. Y., T. L. Lauderdale, S. M. Wang, J. M. Wu, Y. J. Yang, and C. C. Liu. 2008. Health care-associated endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin. J. Clin. Microbiol. 46:810-813.
6. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement; M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Enright, M. C., N. P. Day, C. E. Davies, S. J. Peacock, and B. Spratt. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015. (Pubitemid 30140551)
8. Fitzgibbon, M. M., A. S. Rossney, and B. O'Connell. 2007. Investigation of reduced susceptibility to glycopeptides among methicillin-resistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of heterogeneously glycopeptide-intermediate S. aureus. J. Clin. Microbiol. 45:3263-3269.
9. Fowler, V. G., Jr., H. W. Boucher, G. R. Corey, E. Abrutyn, A. W. Karchmer, M. E. Rupp, D. P. Levine, H. F. Chambers, F. P. Tally, G. A. Vigliani, C. H. Cabell, A. S. Link, I. DeMeyer, S. G. Filler, M. Zervos, P. Cook, J. Parsonnet, J. M. Bernstein, C. S. Price, G. N. Forrest, G. Fatkenheuer, M. Gareca, S. J. Rehm, H. R. Brodt, A. Tice, and S. E. Cosgrove. 2006. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N. Engl. J. Med. 355:653-665.
10. Galen, R. S., and S. R. Gambino. 1975. Beyond normality: the predictive value and efficiency of medical diagnoses, p. 16-17. John Wiley & Sons, Inc., New York, NY.
11. Gilot, P., G. Lina, T. Cochard, and B. Poutrel. 2002. Analysis of the genetic variability of genes encoding the RNA III-activating components Agr and TRAP in a population of Staphylococcus aureus strains isolated from cows with mastitis. J. Clin. Microbiol. 40:4060-4067.
12. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136.
13. Howden, B. P., P. D. Johnson, P. B. Ward, T. P. Stinear, and J. K. Davies. 2006. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob. Agents Chemother. 50:3039-3047.
14. Howe, R. A., M. Wootton, T. R. Walsh, P. M. Bennett, and A. P. Macgowan. 2000. Heterogeneous resistance to vancomycin in Staphylococcus aureus. J. Antimicrob. Chemother. 45:130-132.
15. Huang, Y. C., L. H. Su, T. L. Wu, C. E. Liu, T. G. Young, P. Y. Chen, P. R. Hseuh, and T. Y. Lin. 2004. Molecular epidemiology of clinical isolates of methicillin-resistant Staphylococcus aureus in Taiwan. J. Clin. Microbiol. 42:307-310.
16. Kim, H. B., W. B. Park, K. D. Lee, Y. J. Choi, S. W. Park, M. D. Oh, E. C. Kim, and K. W. Choe. 2003. Nationwide surveillance for Staphylococcus aureus with reduced susceptibility to vancomycin in Korea. J. Clin. Microbiol. 41:2279-2281.
17. Ko, K. S., J. Y. Lee, J. Y. Suh, W. S. Oh, K. R. Peck, N. Y. Lee, and J. H. Song. 2005. Distribution of major genotypes among methicillin-resistant Staphylococcus aureus clones in Asian countries. J. Clin. Microbiol. 43:421-426.
18. Koreen, L., S. V. Ramaswamy, E. A. Graviss, S. Naidich, J. M. Musser, and B. N. Kreiswirth. 2004. spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. J. Clin. Microbiol. 42:792-799.
19. Liu, C., and H. F. Chambers. 2003. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob. Agents Chemother. 47:3040-3045.
20. Liu, Y., H. Wang, N. Du, E. Shen, H. Chen, J. Niu, H. Ye, and M. Chen. 2009. Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals. Antimicrob. Agents Chemother. 53:512-518.
21. Moise-Broder, P. A., G. Sakoulas, G. M. Eliopoulos, J. J. Schentag, A. Forrest, and R. C. Moellering, Jr. 2004. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin. Infect. Dis. 38:1700-1705.
22. Ruppitsch, W., A. Indra, A. Stöger, B. Mayer, S. Stadlbauer, G. Wewalka, and F. Allerberger. 2006. Classifying spa types in complexes improves interpretation of typing results for methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 44:2442-2448. (Pubitemid 44092409)
23. Rybak, M. J., S. N. Leonard, K. L. Rossi, C. M. Cheung, H. S. Sader, and R. N. Jones. 2008. Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007). J. Clin. Microbiol. 46:2950-2954.
24. Sakoulas, G., G. M. Eliopoulos, R. C. Moellering, Jr., R. P. Novick, L. Venkataraman, C. Wennersten, P. C. DeGirolami, M. J. Schwaber, and H. S. Gold. 2003. Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance? J. Infect. Dis. 187:929-938.
25. Song, J. H., K. Hiramatsu, J. Y. Suh, K. S. Ko, T. Ito, M. Kapi, S. Kiem, Y. S. Kim, W. S. Oh, K. R. Peck, and N. Y. Lee. 2004. Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob. Agents Chemother. 48:4926-4928.
26. Tenover, F. C., and R. C. Moellering, Jr. 2007. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin. Infect. Dis. 44:1208-1215.
27. Tsuji, B. T., M. J. Rybak, K. L. Lau, and G. Sakoulas. 2007. Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 51:1089-1091.
28. Unal, S., J. Hoskins, J. E. Flokowitsch, C. Y. Wu, D. A. Preston, and P. L. Skatrud. 1992. Detection of methicillin-resistant staphylococci by using the polymerase chain reaction. J. Clin. Microbiol. 30:1685-1691.
29. Walsh, T. R., A. Bolmstrom, A. Qwarnstrom, P. Ho, M. Wootton, R. A. Howe, A. P. MacGowan, and D. Diekema. 2001. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 39:2439-2444.
30. Walsh, T. R., and R. A. Howe. 2002. The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Annu. Rev. Microbiol. 56:657-675.
31. Wootton, M., R. A. Howe, R. Hillman, T. R. Walsh, P. M. Bennett, and A. P. MacGowan. 2001. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J. Antimicrob. Chemother. 47:399-403.
32. Wootton, M., A. P. MacGowan, T. R. Walsh, and R. A. Howe. 2007. A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 45:329-332.
33. Wootton, M., T. R. Walsh, and A. P. MacGowan. 2005. Evidence for reduction in breakpoints used to determine vancomycin susceptibility in Staphylococcus aureus. Antimicrob. Agents Chemother. 49:3982-3983.
34. Xiao, Y. H., J. Wang, and Y. Li. 2008. Bacterial resistance surveillance in China: a report from Mohnarin 2004-2005. Eur. J. Microbiol. Infect. Dis. 27:697-708.
35. Zhang, K., J. A. McClure, S. Elsayed, T. Louie, and J. M. Conly. 2005. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 43:5026-5033. (Pubitemid 41483999)